|
WO2020123602A1
|
|
Multigene construct for immune-modulatory protein expression and methods of use
|
|
TW202039537A
|
|
Plasmid constructs for treating cancer and methods of use
|
|
CA3098615A1
|
|
Electroporation systems, methods, and apparatus
|
|
US2020246612A1
|
|
Systems and methods for detecting fault conditions in electroporation therapy
|
|
WO2018229696A1
|
|
Multigene construct for immune-modulatory protein expression and methods of use
|
|
AU2017331275A1
|
|
Modulating responses to checkpoint inhibitor therapy
|
|
US2019153469A1
|
|
Plasmid Constructs For Heterologous Protein Expression And Methods Of Use
|
|
WO2016161201A2
|
|
Systems and methods for improved tissue-sensing based electroporation
|
|
US2019117964A1
|
|
Systems and Methods for Improved Tissue-Sensing Based Electroporation
|
|
WO2016154473A1
|
|
Method for the treatment of malignancies
|
|
CA2973390A1
|
|
Method for the treatment of malignancies
|
|
EP2911736A2
|
|
Electroporation device
|
|
AU2012201850A1
|
|
Method and device for treating microscopic residual tumors remaining in tissues following surgical resection
|
